Nervonik Completes First-in-Human Clinical Trial of Nerve Stimulation Technology for Chronic Pain Treatment

Nervonik, a medical device startup company focusing on peripheral nerve stimulation (PNS) for the treatment of chronic pain, has successfully completed the first-in-human clinical study. PNS is a rapidly growing therapy space for the multibillion-dollar chronic pain market. The Nervonik PNS device utilizes proprietary technology, originally developed in Dr.